【Media Pickup】Launch of J-Kinso Bank featured in the The Nikkei and Forbes Japan

April 4, 2024 – Tokyo, Japan 

Launch of J-Kinso Bank, Japan’s first intestinal microbiota bank to utilize intestinal microbiota for research and development of medical technology and pharmaceuticals, has been featured in The Nikkei, Japan’s top daily financial and business newspaper, as well as Forbes Japan. The article covers J-Kinso’s start of operations and its effort to recruit stool donors. 

■The Nikkei Online (in Japanese) 
“Metagen Therapeutics Recruiting Intestinal Microbiota Donors, to Utilize in Medicine” 

■Forbes JAPAN Web-News (in Japanese) 
“Hope in Stool Donation for Patients with Intractable Diseases, Japan’s First Intestinal Microbiota Bank” 

Details of Intestinal Microbiota Donor Candidate registration can be found at the following (in Japanese only) 

J-Kinsoバンク | 腸内細菌叢バンク

www.j-kinso-bank.com

As a leading company of medicine and drug discovery based on research on intestinal microbiota in Japan, Metagen Therapeutics will strive to provide medical services and drugs to patients in Japan and around the world.